Healthcare
M&A Advisory
Pharmaceutical
Research
Global
M&A Advisory
Lazard
Full Credential Description
UCB. Belgium, United States. Announced Date 19/01/2022. Closed Date 07/03/2022. Deal value: $1900m. UCB to acquire Zogenix. Industry: UCB is a global biopharmaceutical company specializing in the research, development, and commercialization of innovative medicines and solutions for people with severe diseases in immunology and neurology.